STMN2 and Alzheimer disease: Western blotting analysis of AD brain homogenates revealed a downward trend in GAP43, STMN2, and TDP‐43 protein levels; however, the differences were not statistically significant, most likely due to the small sample sizes and high data variability (Figure 6B,C).